Atelerix, a biotech company specializing in cell preservation using hydrogel encapsulation technology, has partnered with Frontier Space, a UK-based space biotechnology company, to validate Atelerix’s technology for preserving biological samples during space missions. This collaboration focuses on improving sample quality and reducing associated costs within microgravity research. The partnership will assess Atelerix’s patented alginate hydrogel encapsulation technology for ambient temperature preservation and transport of suspended mammalian cells, organoids, and organ-on-chip models. This approach aims to address key bottlenecks in microgravity research by simplifying sample transport and handling, reducing preservation-related payload mass and risk, and evaluating sample integrity for post-flight analysis. The companies intend to remove reliance on cold-chain logistics, a significant operational complexity and risk factor. Frontier Space provides in-space R&D services, leveraging microgravity conditions to enhance protein crystallization, 3D cell culture, and accelerated ageing. The agreement outlines Atelerix’s provision of preservation products, protocols, and technical support, while Frontier Space will identify relevant use cases, support design and execution of validation work, and integrate the technology within its in-space R&D capabilities. Launch opportunities are targeted throughout 2027. The collaboration seeks to improve access to pharmaceutical research in orbit by making space-based missions more practical and cost-effective. The parties believe that the technology can reduce reliance on bulky cryogenic storage while maintaining sample quality for post-flight analysis. This partnership represents a route to test the benefits of the approach for microgravity research.
Atelerix and Frontier Space partner to enable biological sample preservation for space missions
Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced a partnership with Frontier Space, a UK based space biotechnology company building platform technology for in-orbit R&D and biomanufacturing.
Recommended Medical News
All news →
Study discovers shared vocal patterns between birds and humans
McGill University researchers have identified "universal" vocal patterns across hundreds of bird species and found that many of the same patterns also appear in human song and speech from cultures around the world.
Curiox Biosystems strengthens commercial leadership to expand adoption of centrifuge-free sample preparation
Curiox Biosystems Inc (Curiox), a provider of centrifuge-free (C-FREE™) sample preparation technologies for reproducible, automated flow cytometry workflows, today announced the expansion of its senior commercial team and the formation of a Strategic Advisory Board (SAB).
ATCC selected by ARPA-H to support next-generation BioStabilization technologies
ATCC has been selected by the Advanced Research Projects Agency for Health (ARPA-H) as an affiliate to provide independent verification and validation (IV&V) for its BioStabilization Systems (BoSS) program.
Mutated neutrophils may trigger immune attacks in lupus
Scientists at La Jolla Institute for Immunology (LJI) and the University of Washington (UW) have discovered that patients with lupus have unusual mutations that may turn their bodies into battlegrounds.